Long-term clinical outcome of oral immunotherapy in adults with milk, peanut, and egg allergy: A pilot study
The Journal of Allergy and Clinical Immunology: In Practice · 2024
DOI: 10.1016/j.jaip.2023.10.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024. Verfasst von Tuuli Thomander und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Programme in Clinical Research, University of Helsinki, Helsinki, Finland; The Heart and Lung Center, Helsinki University Hospital, Universi…. Hauptthemen laut MEDLINE: Egg Hypersensitivity, Peanut Hypersensitivity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In Europe, the lifetime prevalence of self-reported physician-diagnosed food allergies in adults is 4.7%.1 Strict allergen avoidance, oral immunotherapy (OIT), and sublingual immunotherapy are treatment options for food allergies.2,3 A recent study, with inclusion criteria of 5 mg of allergen protein tolerance in oral food challenge (OFC) before OIT, suggested that adults experience more adverse events and more often failed OIT than children and adolescents.4 Information on OIT and its long-term outcomes in adults remains limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Doctoral Programme in Clinical Research, University of Helsinki, Helsinki, Finland; The Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Electronic address: tuuli.thomander…
- Department of Allergology, Skin and Allergy Hospital, Inflammation Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland; Department of Otorhinolaryngology, Kuopio University Hospital and Schoo…
- Department of Allergology, Skin and Allergy Hospital, Inflammation Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
- The Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Zitieren
APA
Thomander, T., Toppila-Salmi, S., Palosuo, K., Voutilainen, H., Kukkonen, K., Pallasaho, P., & Kauppi, P. (2024). Long-term clinical outcome of oral immunotherapy in adults with milk, peanut, and egg allergy: A pilot study. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.10.047
Vancouver
Thomander T, Toppila-Salmi S, Palosuo K, Voutilainen H, Kukkonen K, Pallasaho P, et al. Long-term clinical outcome of oral immunotherapy in adults with milk, peanut, and egg allergy: A pilot study. The Journal of Allergy and Clinical Immunology: In Practice. 2024. doi:10.1016/j.jaip.2023.10.047
BibTeX
@article{Thomander2024,
author = {Thomander, Tuuli and Toppila-Salmi, Sanna and Palosuo, Kati and Voutilainen, Helena and Kukkonen, Kaarina and Pallasaho, Paula and Kauppi, Paula},
title = {Long-term clinical outcome of oral immunotherapy in adults with milk, peanut, and egg allergy: A pilot study},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
doi = {10.1016/j.jaip.2023.10.047}
}
EUVIMED